A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether Rebamipide facilitate the healing of
inflamed mucosa as an adjuvant regimen in erosive reflux esophagitis (ERE).